Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Ahmed Mushfiq Mobarak wants to find out what makes antipoverty programs effective

The Yale economist has spent his career seeking out what’s most effective in helping the poor.

A portrait illustration of Ahmed Mushfiq Mobarak.
A portrait illustration of Ahmed Mushfiq Mobarak.
Rebecca Clarke for Vox

No one likes failure. That’s especially true when failure leads to terrible consequences: a family not being fed, constant power outages, widespread death from a pandemic.

The financial and human consequences of failure are even bigger for decisions at the level of a region or whole country. Growing up in Bangladesh, Ahmed Mushfiq Mobarak, an economics professor at Yale, witnessed how the actions of the government and NGOs could impact lives for better or worse. Untangling how to make these programs work for as many people as possible is what Mobarak has done every day for the last 20 years.

Mobarak has worked in areas from air pollution to sanitation, but perhaps the most famous example from his research, illustrating the importance of scaling up such work, is seasonal migration. In widely cited experiments, Mobarak’s team found that giving low-income people in Bangladesh some money to temporarily move to the city to work during the “lean season” increased their family incomes.

This experiment was part of an effort to make the international development field more evidence-based. Through randomized controlled trials (RCTs), researchers can test the effectiveness of programs — in this case, giving people money to temporarily migrate to find a job — with some randomly selected people, and comparing the outcomes of the people who got the program with those who didn’t.

The findings sounded great, but the story doesn’t end there. The migration paper inspired the nonprofit initiative No Lean Season, which gave a travel subsidy to people in Bangladesh who wanted to seasonally migrate for work. But when the program was scaled to millions of people, it had no effect. Based on the evidence at scale, No Lean Season stopped in 2019.

That’s part of the learning process for research. And while finding a program doesn’t work at scale might seem like a setback, being able to test whether policies work at different levels and adjust accordingly is a very good thing and something more governments and policy-making organizations should do.

Lessons on scale are vital to consider for policy based on randomized experiments, which is a focus of Mobarak’s work at the Yale Research Initiative on Innovation and Scale (Y-RISE).

Y-RISE works in areas as varied as microfinance, refugee integration, and childhood development. Bringing programs in areas like health and agriculture to scale carries with it lots of challenges — changes in government behavior, effects on macroeconomic growth, implementation difficulties — but if done well, it can improve the lives of millions of vulnerable people.

Y-RISE aims to do just that.

“The world becomes vastly more complicated when a program is scaled up,” he said at the launch of the initiative in 2018. A program that might work with a couple of villages might not work on a national level; a program that works in Bangladesh is not guaranteed to work in Kenya. And when a program with promising results is tested multiple times and scaled in the real world, we can gain a lot of insight into what parts might work in the future and how to reform a program — or stop funding it altogether.

Another area necessary for large-scale policy that Mobarak studies is “spillover effects” — the positive or negative effects of programs on people who don’t receive them. In a study on latrine subsidies, Mobarak and a team found latrine usage — which decreases the spread of pathogens — increased not only among subsidy recipients but also their neighbors, and that these effects were higher among poorer people in denser neighborhoods. While this hasn’t yet been tested at a larger scale, information about who programs will have the largest impact on is part of the learning process governments can use when deciding who to reach with limited resources.

In keeping with his work on scale and behavior, Mobarak’s current projects include ongoing research into pandemic response in low- and middle-income countries, and how to promote technology adoption. The world is ever-changing, and his research continues to provide insight on the varied policies that allow people to thrive and catalyze economic growth.

“If we better understand what constraints people are under,” he said in an interview with Yale, “we’re able to design policies to address those constraints.”

Future Perfect
The tax code rewards generosity. But probably not yours.The tax code rewards generosity. But probably not yours.
Future Perfect

Why giving to charity is a better deal if you’re rich.

By Sara Herschander
Technology
The case for AI realismThe case for AI realism
Technology

AI isn’t going to be the end of the world — no matter what this documentary sometimes argues.

By Shayna Korol
Climate
The electric grid’s next power source might be sitting in your drivewayThe electric grid’s next power source might be sitting in your driveway
Climate

Batteries that could help drive the switch to renewable energy are already, well, driving.

By Matt Simon
Future Perfect
Am I too poor to have a baby?Am I too poor to have a baby?
Future Perfect

How society convinced us that childbearing is morally wrong without a fat budget.

By Sigal Samuel
Future Perfect
How Austin’s stunning drop in rents explains housing in AmericaHow Austin’s stunning drop in rents explains housing in America
Future Perfect

We finally have some good news about housing affordability.

By Marina Bolotnikova
Future Perfect
Ozempic just got cheap enough to change the worldOzempic just got cheap enough to change the world
Future Perfect

Why the $14 drug could reshape global health.

By Pratik Pawar